NeuroMetrix encouraged by Phase II Quell data
NeuroMetrix reported trial data for its wireless transcutaneous electric nerve stimulation device for chemotherapy-induced peripheral neuropathy.
Nykode collaborates with Roche for an upcoming trial in cervical cancer
Nacuity achieves target enrolment in RP therapy trial
Pfizer’s haemophilia drug succeeds in Phase III trial
Positive Phase I results for Prader-Willi Syndrome drug
selectION reports safety results from SAD stage of si-544 Phase Ib trial
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreCocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan
It’s a match! Connecting patients to clinical trials with AI